Emulate, Inc. is a private company focused on commercializing Organs-on-Chips as an automated human bioemulation platform that achieves a new standard for mimicking true human physiology so that responses to medicines, chemicals and diseases can be accurately predicted. Through co-innovation with collaborators and internal programs, Emulate is advancing product innovation, design and safety across a range of applications in drug development, personalized medicine, agriculture and chemical-based consumer products.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 07/28/14 | $12,000,000 | Series A |
Cedars-Sinai Medical Center Hansjorg Wyss NanoDimension | undisclosed |
| 03/28/16 | $28,000,000 | Series B |
ATEL Capital Group Cedars-Sinai Medical Center Hansjorg Wyss NanoDimension OS Fund | undisclosed |
